Phreesia (FRA:19P) Interest Expense: €-7.5 Mil (TTM As of Apr. 2026)


FRA:19P Phreesia Inc FRA:19P
65 GF Score
Price €9.50
GF Value €23.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Phreesia Interest Expense?

Phreesia FRA:19P +2.15% 65 Interest Expense is €-7.5 Mil as of Apr. 2026. GuruFocus rates FRA:19P with a GF Score™ of 65/100 and a GF Value™ of €23.45 (Possible Value Trap). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Phreesia's interest expense for the three months ended in Apr. 2026 was € -2.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2026 was €-7.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Phreesia's Operating Income for the three months ended in Apr. 2026 was € 5.8 Mil. Phreesia's Interest Expense for the three months ended in Apr. 2026 was € -2.0 Mil. Phreesia's Interest Coverage for the quarter that ended in Apr. 2026 was 2.93. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Phreesia  (FRA:19P) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Phreesia's Interest Expense for the three months ended in Apr. 2026 was €-2.0 Mil. Its Operating Income for the three months ended in Apr. 2026 was €5.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2026 was €73.7 Mil.

Phreesia's Interest Coverage for the quarter that ended in Apr. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Apr. 2026 )/Interest Expense (Q: Apr. 2026 )
=-1*5.77/-1.966
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Phreesia Interest Expense Historical Data

* Premium members only.

The historical data trend for Phreesia's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia Interest Expense Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Interest Expense
Get a 7-Day Free Trial Premium Member Only -1.03 -1.31 -1.70 -2.27 -5.92

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.39 -0.34 -0.28 -4.94 -1.97
FRA:19P
65GF Score
Phreesia Inc FRA:19P
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phreesia Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-7.5 Mil mean?
Phreesia (FRA:19P) has a Interest Expense of €-7.5 Mil as of Apr. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Phreesia and its competitors.
Is Phreesia's Interest Expense too high?
Phreesia's current Interest Expense is €-7.5 Mil. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's Interest Expense compare to EVH and CTEV?
Phreesia's Interest Expense of €-7.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Phreesia and its competitors. Phreesia's current Interest Expense is €-7.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (FRA:19P) is currently considered Possible Value Trap. The stock's GF Value™ is €23.45, compared to a current price of €9.50 — trading 59.5% below its estimated fair value. The current Interest Expense is €-7.5 Mil. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Phreesia (FRA:19P), the current Interest Expense is €-7.5 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (FRA:19P) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of €9.50 is trading 59.5% below its estimated GF Value™ of €23.45. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for FRA:19P:

  • Interest Expense: €-7.5 Mil
  • GF Value™: €23.45 vs. price of €9.50 (59.5% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the FRA:19P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Phreesia Business Description

Other Exchanges PHR:USA
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for FRA:19P

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.50
Price
€23.45
GF Value